Impact of Standardized Screening Protocols for Cystic Fibrosis–Related Diabetes in a Pediatric Population

Conclusion

The use of a structured process developed by a multidisciplinary team resulted in improved CFRD screening rates. In addition to outpatient protocols, it is critical to develop inpatient glucose testing protocols in order to capture patients who are only seen at times of exacerbation. Even in this era of treatment at a cellular level with correctors and potentiators, early detection and treatment of CFRD is essential for optimal clinical outcomes [1,5,17]. The next step for us is to sustain our gains and to improve endocrine care facilitation. We hope this report may guide other teams and institutional leadership in their efforts to improve identification of individuals with CFRD.

Acknowledgments: We would like to acknowledge Gautham Suresh, MD, Jennifer Abuzzahab, MD, Robert Payne, MD, and Andrew Flood, PhD, for their assistance in the preparation of our manuscript. We also acknowledge John Nash, MSW, LMSW, who provided us tools and coaching throughout the Learning and Leadership Collaborative.

Corresponding author: Lisa Read, MPH, 2525 Chicago Ave. South, MS 17-750, Minneapolis, MN 55404, lisa.read@childrensmn.org.

Funding/support. This work was supported by a grant from the Cystic Fibrosis Foundation for the Learning and Leadership Collaborative: Cystic Fibrosis-Related Diabetes Care (MCNAMA11Q10, to Dr. McNamara).